YIFAN PHARMACEUTICAL CO (SZSE:002019) Long-Term Capital Lease Obligation : ¥59 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Long-Term Capital Lease Obligation?

YIFAN PHARMACEUTICAL CO's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥59 Mil.

YIFAN PHARMACEUTICAL CO's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (¥68 Mil) to Dec. 2023 (¥67 Mil) and declined from Dec. 2023 (¥67 Mil) to Mar. 2024 (¥59 Mil).

YIFAN PHARMACEUTICAL CO's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (¥90 Mil) to Dec. 2022 (¥81 Mil) and declined from Dec. 2022 (¥81 Mil) to Dec. 2023 (¥67 Mil).

YIFAN PHARMACEUTICAL CO Long-Term Capital Lease Obligation Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Long-Term Capital Lease Obligation Chart

YIFAN PHARMACEUTICAL CO Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

72.65

89.80

80.69

66.73

YIFAN PHARMACEUTICAL CO Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															81.10	75.75	68.01	66.73	59.30

YIFAN PHARMACEUTICAL CO (SZSE:002019) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

YIFAN PHARMACEUTICAL CO Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300

Website

https://en.yifanyy.com

YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

Executives

Ye Yi Qun	Director
Zhang Da Wei	Executives
Geng Yu Hong	Executives
Feng De Qi	Directors, Directors, and Executives
Zhou Ben Yu	Director
Lin Xing	Directors, executives
Yu Hai Xia	Executives
Cheng Xian Feng	Directors, executives
Xu Guo Han	Supervisors
Cao Shi Mei	Director
Lin Guan Yu	Director
Zhang Lian Chun	Executives
Guo Xin Fu	Director
Zheng Shi Ming	Supervisors
Yin Hang Hua	Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines